KSE - Delayed Quote KRW

ORIENT BIO Inc. (002630.KS)

1,179.00
-109.00
(-8.46%)
At close: May 30 at 3:30:05 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
29,460,919.62
28,005,127.32
28,819,028.14
26,276,462.47
52,020,405.17
Cost of Revenue
22,929,551.19
18,420,724.34
18,994,584.49
17,262,893.34
32,792,899.80
Gross Profit
6,531,368.43
9,584,402.98
9,824,443.65
9,013,569.13
19,227,505.37
Operating Expense
5,151,728.71
5,129,622.94
6,359,177.05
12,794,323.15
17,368,000.66
Operating Income
1,379,639.72
4,454,780.04
3,465,266.60
-3,780,754.02
1,859,504.71
Net Non Operating Interest Income Expense
1,484,656.93
2,221,213.23
2,386,405.31
427,357.76
58,026.13
Pretax Income
1,966,034.03
12,871,053.37
-12,590,731.83
-3,361,205.25
-15,667,848.55
Tax Provision
--
--
-167,024.01
69,124.92
-34,442.45
Net Income Common Stockholders
1,905,608.41
12,871,053.37
-12,423,707.81
34,198,169
-15,633,538.12
Basic EPS
16.40
109.00
-105.00
288.00
-138.00
Diluted EPS
16.40
109.00
-105.00
288.00
-138.00
Basic Average Shares
118,921.79
118,083.06
118,321.03
118,743.64
113,226.08
Diluted Average Shares
118,921.79
118,083.06
118,321.03
118,743.64
113,226.08
Total Operating Income as Reported
-3,327,029.02
-645,945.76
1,452,807.02
-3,780,753.83
1,859,504.59
Rent Expense Supplemental
83,285.51
67,322.87
97,308.40
64,365.13
21,908.36
Total Expenses
28,081,279.90
23,550,347.28
25,353,761.54
30,057,216.49
50,160,900.46
Net Income from Continuing & Discontinued Operation
1,905,608.41
12,871,053.37
-12,423,707.81
34,198,169
-15,633,538.12
Normalized Income
3,574,999.38
8,489,041.33
5,212,755.61
-2,975,861
-2,478,364.96
Interest Income
1,736,099.83
2,278,113.44
1,524,754.76
818,578.37
620,076.51
Interest Expense
198,643.07
56,900.37
252,281.87
432,884.97
559,692.96
Net Interest Income
1,484,656.93
2,221,213.23
2,386,405.31
427,357.76
58,026.13
EBIT
2,164,677.10
12,927,953.74
-12,338,449.96
-2,928,320.28
-15,108,155.59
EBITDA
4,247,198.05
15,611,689.36
-9,248,325.48
997,248.68
-10,416,839.76
Reconciled Cost of Revenue
22,929,551.19
18,420,724.34
18,994,584.49
17,262,893.34
32,792,899.80
Reconciled Depreciation
2,082,520.95
2,683,735.62
3,090,124.48
3,925,568.96
4,691,315.83
Net Income from Continuing Operation Net Minority Interest
1,905,608.41
12,871,053.37
-12,423,707.81
-3,430,330.62
-15,633,538.12
Total Unusual Items Excluding Goodwill
-2,196,567.06
5,765,805.32
-17,873,567.58
-626,854.65
-13,184,155.74
Total Unusual Items
-2,196,567.06
5,765,805.32
-17,873,567.58
-626,854.65
-13,184,155.74
Normalized EBITDA
6,443,765.11
9,845,884.04
8,625,242.10
1,624,103.33
2,767,315.98
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-527,176.09
1,383,793.28
-237,104.16
-172,385.03
-28,982.58
3/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

115180.KQ Qurient Co., Ltd.
10,620.00
-2.84%
 
475960.KQ TOMOCUBE
25,500.00
-4.32%
 
347850.KQ D&D Pharmatech
86,500.00
+1.76%
 
226950.KQ OliX Pharmaceuticals, Inc
54,300.00
+8.38%
 
127120.KQ JS Link, Inc.
8,640.00
-0.46%
 
310210.KQ Voronoi, Inc.
105,700.00
-1.21%
 
087010.KQ Peptron, Inc.
232,500.00
+3.33%
 
950160.KQ Kolon TissueGene, Inc.
40,600.00
0.00%
 
4592.T SanBio Company Limited
3,015.00
-11.71%
 
214450.KQ PharmaResearch Co., Ltd.
451,000.00
+1.81%